Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kotra Industries BhdXKLS:0002 -0.53%75 Equity-to-Asset is 0.78 as of Mar. 2026, which is at its 10-year median of 0.78. GuruFocus rates XKLS:0002 with a GF Score™ of 75/100 and a GF Value™ of RM4.36 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Kotra Industries Bhd ranks better than 77.31% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Kotra Industries Bhd's Total Stockholders Equity for the quarter that ended in Mar. 2026 was RM289.1 Mil. Kotra Industries Bhd's Total Assets for the quarter that ended in Mar. 2026 was RM371.2 Mil.
Therefore, Kotra Industries Bhd's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.78.
The historical rank and industry rank for Kotra Industries Bhd's Equity-to-Asset or its related term are showing as below:
XKLS:0002'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.52 Med: 0.78 Max: 0.85
Current: 0.78
During the past 13 years, the highest Equity to Asset Ratio of Kotra Industries Bhd was 0.85. The lowest was 0.52. And the median was 0.78.
XKLS:0002's Equity-to-Asset is ranked better than 77.31% of 1005
companies
in the Drug Manufacturers industry
Industry Median: 0.6
vs XKLS:0002: 0.78
Kotra Industries Bhd (XKLS:0002) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Kotra Industries Bhd Equity-to-Asset Related Terms
Kotra Industries Bhd Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Kotra Industries Bhd's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0002 vs ZTS, UTHR, VTRS: Equity-to-Asset Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Kotra Industries Bhd's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kotra Industries Bhd Equity-to-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kotra Industries Bhd's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Kotra Industries Bhd's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Kotra Industries Bhd's Equity to Asset Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kotra Industries Bhd (XKLS:0002) has a Equity-to-Asset of 0.78 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Kotra Industries Bhd and its competitors. This is near median its historical median of 0.78. Over the past decade, Kotra Industries Bhd's Equity-to-Asset has ranged from 0.52 to 0.85. According to the industry distribution chart, Kotra Industries Bhd ranks #228 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 22.7%.
Is Kotra Industries Bhd's Equity-to-Asset too high?
Kotra Industries Bhd's current Equity-to-Asset of 0.78 is near median its 10-year median of 0.78. Over the past 10 years, this metric has ranged from a low of 0.52 to a high of 0.85. The Drug Manufacturers industry median Equity-to-Asset is 0.60. Kotra Industries Bhd's value of 0.78 is 30% above this industry median. Based on the distribution chart, Kotra Industries Bhd ranks #228 out of 1005 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Kotra Industries Bhd has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kotra Industries Bhd's Equity-to-Asset compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kotra Industries Bhd ranks #228 out of 1005 companies for Equity-to-Asset. This places Kotra Industries Bhd in the top 23% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.60. Kotra Industries Bhd's value of 0.78 is 30% above this benchmark. Historically, Kotra Industries Bhd's own Equity-to-Asset has ranged from 0.52 to 0.85 over the past decade. While the company's 10-year median is 0.78 vs. the industry median of 0.60, Kotra Industries Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.60, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kotra Industries Bhd's current Equity-to-Asset of 0.78 is 30% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Kotra Industries Bhd and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kotra Industries Bhd's current Equity-to-Asset is 0.78, which is near median its own 10-year median of 0.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kotra Industries Bhd stock overvalued right now?
Based on GuruFocus' analysis, Kotra Industries Bhd (XKLS:0002) is currently considered Modestly Undervalued. The stock's GF Value™ is RM4.36, compared to a current price of RM3.73 — trading 14.4% below its estimated fair value. The current Equity-to-Asset is 0.78, which is near median its 10-year median of 0.78 and 30% above the Drug Manufacturers industry median of 0.60. Kotra Industries Bhd's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Kotra Industries Bhd (XKLS:0002), the current Equity-to-Asset is 0.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kotra Industries Bhd (XKLS:0002) Overvalued in 2026?
Based on GuruFocus' analysis, Kotra Industries Bhd stock appears to be undervalued.
The current stock price of RM3.73 is trading 14.4% below its estimated GF Value™ of RM4.36.
GuruFocus considers Kotra Industries Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0002:
Equity-to-Asset: 0.78 (near median its 10-year median of 0.78)
GF Value™: RM4.36 vs. price of RM3.73 (14.4% below fair value)
Industry Position: 30% above the Drug Manufacturers median (#228 of 1005)
No single metric tells the full story. See the XKLS:0002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kotra Industries Bhd is a Malaysian pharmaceutical company engaged in the development, manufacturing, and supply of pharmaceutical and healthcare products supporting all life stages. Its portfolio includes life-saving medicines, OTC supplements, and nutrition products. The Group markets three core brands: Appeton, offering health supplements and nutrition across all age groups; Vaxcel, providing injectable medicines for infectious diseases, kidney care, and gastroenterology; and Axcel, specializing in oral and topical medicines for paediatrics, dermatology, and infectious diseases. The company operates in Malaysia and overseas, with the majority of revenue derived from Malaysia.
75GF Score
Get the complete analysis for XKLS:0002
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0002 has been successfully added to your 
